Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens ; volume:8 ; number:11 ; day:19 ; month:10 ; year:2018 ; pages:1-10 ; date:11.2018
Blood cancer journal ; 8, Heft 11 (19.10.2018), 1-10, 11.2018
- Creator
- Contributor
-
Herold, Nikolas
Myrberg, Ida Hed
Tsesmetzis, Nikolaos
Rudd, Sean G.
Henter, Jan-Inge
Schaller, Torsten
Ng, Siok-Bian
Chng, Wee Joo
Yan, Benedict
Ng, Chin Hin
Ravandi, Farhad
Andreeff, Michael
Kantarjian, Hagop M.
Medeiros, L. Jeffrey
Xagoraris, Ioanna
Khoury, Joseph D.
SpringerLink (Online service)
- DOI
-
10.1038/s41408-018-0134-z
- URN
-
urn:nbn:de:101:1-2018112622264327208184
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rassidakis, Giorgios
- Herold, Nikolas
- Myrberg, Ida Hed
- Tsesmetzis, Nikolaos
- Rudd, Sean G.
- Henter, Jan-Inge
- Schaller, Torsten
- Ng, Siok-Bian
- Chng, Wee Joo
- Yan, Benedict
- Ng, Chin Hin
- Ravandi, Farhad
- Andreeff, Michael
- Kantarjian, Hagop M.
- Medeiros, L. Jeffrey
- Xagoraris, Ioanna
- Khoury, Joseph D.
- SpringerLink (Online service)
Other Objects (12)
Evaluation of the predictive value of SAMHD1 for cytarabine response in mantle cell lymphoma
Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine
Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
SAMHD1 im malignen Melanom
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
Restriction of diverse retroviruses by SAMHD1
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Evaluation of the predictive value of SAMHD1 for cytarabine response in mantle cell lymphoma
Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine
Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
SAMHD1 im malignen Melanom
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
Restriction of diverse retroviruses by SAMHD1
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Evaluation of the predictive value of SAMHD1 for cytarabine response in mantle cell lymphoma
Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine
Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
SAMHD1 im malignen Melanom
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
Restriction of diverse retroviruses by SAMHD1
Multifaceted roles of SAMHD1 in cancer